Publications by authors named "Miles Avila"

Claim this Profile
B
Breakthrough SARS-CoV-2 Infections in the PROVENT Prevention Trial Were Not Associated With AZD7442 (Tixagevimab/Cilgavimab) Resistant Variants.
Kevin M Tuffy, Bahar Ahani, Anastasia A Aksyuk, Miles Avila, Tyler Brady

J Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for Prevention of Covid-19.
Myron J Levin, Andrew Ustianowski, Stéphane De Wit, Odile Launay, Miles Avila

N Engl J Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis